Filter News
Area of Research
News Topics
- (-) Biomedical (4)
- (-) Isotopes (5)
- (-) Summit (1)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (7)
- Bioenergy (1)
- Computer Science (3)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (3)
- Environment (1)
- Fusion (6)
- Materials Science (5)
- Molten Salt (4)
- Nanotechnology (1)
- Neutron Science (4)
- Nuclear Energy (21)
- Physics (1)
- Polymers (1)
- Space Exploration (2)
- Sustainable Energy (3)
- Transformational Challenge Reactor (3)
- Transportation (3)
Media Contacts
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Scientists at Oak Ridge National Laboratory and the University of Tennessee designed and demonstrated a method to make carbon-based materials that can be used as electrodes compatible with a specific semiconductor circuitry.
Four research teams from the Department of Energy’s Oak Ridge National Laboratory and their technologies have received 2020 R&D 100 Awards.
Radioactive isotopes power some of NASA’s best-known spacecraft. But predicting how radiation emitted from these isotopes might affect nearby materials is tricky
After its long journey to Mars beginning this summer, NASA’s Perseverance rover will be powered across the planet’s surface in part by plutonium produced at the Department of Energy’s Oak Ridge National Laboratory.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.